Chester County News and Community Website
WILMINGTON, DE — Chase Freedom® has announced its rotating cash back categories for the second quarter of 2025, offering cardmembers enhanced rewards on popular spending areas. From April 1 to June …
Chase Freedom Unveils Q2 2025 Cash Back Categories Read More
WILMINGTON, DE — Biopharmaceutical company Incyte (Nasdaq: INCY) has reported encouraging results from its Phase 3 STOP-HS clinical trials evaluating povorcitinib, an oral JAK1 inhibitor, for moderate to severe hidradenitis suppurativa …
Incyte Announces Positive Phase 3 Results for Hidradenitis Suppurativa Treatment Read More
WILMINGTON, DE — NAPIGEN, Inc., a biotechnology company specializing in advanced gene-editing technologies, has received notification from the U.S. Department of Agriculture (USDA) confirming that its gene-edited rice with mitochondrial DNA …
USDA Approval Clears Path for NAPIGEN’s Gene-Edited Rice Read More
WILMINGTON, DE — Diversified LLC is honored to be recognized as one of the Best Places to Work for Financial Advisors in the USA by InvestmentNews. This notable award highlights Diversified’s …
Diversified LLC Named One of the Best Places to Work for Financial Advisors by InvestmentNews Read More
WILMINGTON, DE — Whispeara, a natural hearing supplement, is making waves as a holistic solution for auditory and cognitive health challenges. Developed with carefully selected herbal extracts, vitamins, and minerals, the …
Whispeara Gains Attention as a Breakthrough in Hearing Support Read More
WILMINGTON, DE — Ashland Inc. (NYSE: ASH) has finalized the sale of its Avoca business to Mane, effective March 14, 2025. While the financial terms of the deal remain undisclosed, the …
Ashland Sells Avoca Business to Mane Read More
WILMINGTON, DE — Global Indemnity Group, LLC (NYSE: GBLI) has announced that its Board of Directors approved a distribution payment of $0.35 per common share.
Global Indemnity Announces $0.35 Per Share Distribution for March 2025 Read More WILMINGTON, DE — Global Indemnity Group, LLC (NYSE:GBLI) closed out 2024 with remarkable financial results, posting a 71% rise in net income available to shareholders, reaching $42.8 million or $3.12 per …
Global Indemnity Reports Robust 2024 Financial Performance Read More
WILMINGTON, DE — NiKang Therapeutics® Inc. has achieved a pivotal step in the development of its first-in-class CDK2 degrader, NKT3964, by completing the dosing of the first patient cohort in a …
NiKang Advances CDK2 Degrader with Key Milestone in Cancer Treatment Trial Read More
WILMINGTON, DE & WHIPPANY, NJ — The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility in Whippany, New Jersey, by adding sterile injectable manufacturing capabilities. …
Noramco Group Invests $25 Million to Expand Sterile Injectable Manufacturing Read More